{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:17:36Z","timestamp":1794057456271,"version":"4.8.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ejim.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,5,20]],"date-time":"2017-05-20T17:01:05Z","timestamp":1495299665000},"page":"81-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece"],"prefix":"10.1016","volume":"42","author":[{"given":"Nikolaos K.","family":"Gatselis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Zachou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Lygoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Azariadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinelopi","family":"Arvaniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Spyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Papadamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Koukoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N.","family":"Dalekos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini I.","family":"Rigopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2017.05.006_bb0005","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.22042","article-title":"The causes of primary biliary cirrhosis: convenient and inconvenient truths","volume":"47","author":"Gershwin","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2017.05.006_bb0010","first-page":"55","article-title":"Primary biliary cirrhosis: one disease with many faces","volume":"13","author":"Hirschfield","year":"2011","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.ejim.2017.05.006_bb0015","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/14737159.2016.1217159","article-title":"Molecular diagnostic testing for primary biliary cholangitis","volume":"16","author":"Gatselis","year":"2016","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.ejim.2017.05.006_bb0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2008.06.006","article-title":"The unfinished business of primary biliary cirrhosis","volume":"49","author":"Selmi","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0025","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/00365520310008746","article-title":"Anti-sp100 antibodies in primary biliary cirrhosis","volume":"39","author":"Rigopoulou","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0030","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/gut.2003.036558","article-title":"Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis","volume":"54","author":"Rigopoulou","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2017.05.006_bb0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/08916934.2013.801461","article-title":"Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease","volume":"46","author":"Gatselis","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejim.2017.05.006_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1572-0241.1999.00770.x","article-title":"Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis","volume":"94","author":"Springer","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0045","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.05.006_bb0050","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2017.05.006_bb0055","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.3748\/wjg.v18.i34.4721","article-title":"Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients","volume":"18","author":"Zografos","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ng.631","article-title":"Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis","volume":"42","author":"Hirschfield","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2017.05.006_bb0065","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ng.627","article-title":"Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis","volume":"42","author":"Liu","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2017.05.006_bb0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.789","article-title":"Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis","volume":"43","author":"Mells","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2017.05.006_bb0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1542-3565(04)00678-0","article-title":"From bases to basis: linking genetics to causation in primary biliary cirrhosis","volume":"3","author":"Invernizzi","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0080","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/ije\/26.4.830","article-title":"Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England","volume":"26","author":"Metcalf","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/07853890310018467","article-title":"Autoimmunity and environmental factors in the pathogenesis of primary biliary cirrhosis","volume":"36","author":"Kita","year":"2004","journal-title":"Ann Med"},{"key":"10.1016\/j.ejim.2017.05.006_bb0090","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2004.04.064","article-title":"Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations","volume":"127","author":"Sood","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2017.05.006_bb0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2009.08.001","article-title":"Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty?","volume":"34","author":"Christen","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ejim.2017.05.006_bb0100","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/jhep.2001.23902","article-title":"Molecular mimicry and primary biliary cirrhosis: premises not promises","volume":"33","author":"Van de Water","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2017.05.006_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1568-9972(01)00020-9","article-title":"Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobiotics","volume":"1","author":"Long","year":"2002","journal-title":"Autoimmun Rev"},{"issue":"Suppl. 2","key":"10.1016\/j.ejim.2017.05.006_bb0110","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000440754","article-title":"Geoepidemiology, genetic and environmental risk factors for PBC","volume":"33","author":"Zhang","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.ejim.2017.05.006_bb0115","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1111\/liv.12434","article-title":"Rising incidence and prevalence of primary biliary cirrhosis: a large population-based study","volume":"34","author":"Boonstra","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2017.05.006_bb0120","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1111\/liv.12479","article-title":"Geoepidemiology and space-time analysis of Primary biliary cirrhosis in Crete, Greece","volume":"34","author":"Koulentaki","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2017.05.006_bb0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the L","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clim.2006.01.002","article-title":"Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases","volume":"119","author":"Zachou","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10875-008-9211-6","article-title":"IgA anti-b2GPI antibodies in patients with autoimmune liver diseases","volume":"28","author":"Gabeta","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2017.05.006_bb0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0150","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","author":"Lammers","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2017.05.006_bb0155","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2017.05.006_bb0160","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/apt.12470","article-title":"Review article: autoimmune hepatitis\u2014current management and challenges","volume":"38","author":"Zachou","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2017.05.006_bb0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","article-title":"Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics","volume":"21","author":"Gatselis","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0170","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10875-007-9092-0","article-title":"Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis","volume":"27","author":"Gabeta","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0175","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MEG.0b013e328353753d","article-title":"The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study","volume":"24","author":"Baldursdottir","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0180","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/bmj.281.6243.772","article-title":"Primary biliary cirrhosis: an epidemiological study","volume":"281","author":"Triger","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.ejim.2017.05.006_bb0185","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1053\/jhep.2001.29760","article-title":"The geographical distribution of primary biliary cirrhosis in a well-defined cohort","volume":"34","author":"Prince","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2017.05.006_bb0190","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep.21076","article-title":"Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites","volume":"43","author":"Ala","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2017.05.006_bb0195","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.24597","article-title":"Seasonal variation in the patient diagnosis of primary biliary cirrhosis: further evidence for an environmental component to etiology","volume":"54","author":"McNally","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2017.05.006_bb0200","doi-asserted-by":"crossref","first-page":"896","DOI":"10.2134\/jeq2009.0003","article-title":"Spatial and seasonal patterns of benzene, toluene, ethylbenzene, and xylenes in the Gdansk, Poland and surrounding areas determined using radiello passive samplers","volume":"39","author":"Zabiegala","year":"2010","journal-title":"J Environ Qual"},{"key":"10.1016\/j.ejim.2017.05.006_bb0205","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2017.05.006_bb0210","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","article-title":"Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis","volume":"53","author":"Corpechot","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0215","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.21749","article-title":"Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis","volume":"46","author":"Lazaridis","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2017.05.006_bb0220","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-230X-12-110","article-title":"Primary biliary cirrhosis in a genetically homogeneous population: disease associations and familial occurrence rates","volume":"12","author":"Mantaka","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0225","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MEG.0b013e3282f163ed","article-title":"Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis","volume":"20","author":"Deutsch","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0230","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwt308","article-title":"No rise in incidence but geographical heterogeneity in the occurrence of primary biliary cirrhosis in North East England","volume":"179","author":"McNally","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0235","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jhep.2011.03.031","article-title":"Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis","volume":"56","author":"Corpechot","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2017.05.006_bb0240","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/qjmed\/hcm059","article-title":"Clinical and serological profile of primary biliary cirrhosis in men","volume":"100","author":"Muratori","year":"2007","journal-title":"QJM"},{"key":"10.1016\/j.ejim.2017.05.006_bb0245","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1478-3231.2010.02366.x","article-title":"A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre","volume":"31","author":"Floreani","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2017.05.006_bb0250","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1478-3231.2008.01715.x","article-title":"Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years","volume":"28","author":"Su","year":"2008","journal-title":"Liver Int"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517301826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517301826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T11:56:41Z","timestamp":1535803001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620517301826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":50,"alternative-id":["S0953620517301826"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2017.05.006","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}